These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Novel omega -- 3-derived local mediators in anti-inflammation and resolution. Serhan CN Pharmacol Ther; 2005 Jan; 105(1):7-21. PubMed ID: 15626453 [TBL] [Abstract][Full Text] [Related]
3. Different inflammatory mediators induce inflammation and pain after application of liquid nitrogen to the skin. de Souza RC; Cunha JM; Ferreira SH; Cunha FQ; Lima HC Cryobiology; 2006 Dec; 53(3):319-29. PubMed ID: 17005173 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory mediators in acute pancreatitis. Bhatia M; Brady M; Shokuhi S; Christmas S; Neoptolemos JP; Slavin J J Pathol; 2000 Feb; 190(2):117-25. PubMed ID: 10657008 [TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Lawrence T; Willoughby DA; Gilroy DW Nat Rev Immunol; 2002 Oct; 2(10):787-95. PubMed ID: 12360216 [TBL] [Abstract][Full Text] [Related]
9. Immune and inflammatory mechanisms in neuropathic pain. Moalem G; Tracey DJ Brain Res Rev; 2006 Aug; 51(2):240-64. PubMed ID: 16388853 [TBL] [Abstract][Full Text] [Related]
10. A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation. Reynolds A; Rubin J; Clermont G; Day J; Vodovotz Y; Bard Ermentrout G J Theor Biol; 2006 Sep; 242(1):220-36. PubMed ID: 16584750 [TBL] [Abstract][Full Text] [Related]
11. [Humoral and cellular inflammatory mediators in acute lung injury: friends or enemies? ]. Buccelletti F; Mazzone M; Portale G; Forte P; Bononi F; Mirabella C; Travaglino F; Gentiloni Silveri N Minerva Med; 2003 Jun; 94(3):157-65. PubMed ID: 14605596 [TBL] [Abstract][Full Text] [Related]
12. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Yacoubian S; Serhan CN Nat Clin Pract Rheumatol; 2007 Oct; 3(10):570-9; quiz 1 p following 589. PubMed ID: 17906612 [TBL] [Abstract][Full Text] [Related]
13. [Severe inflammatory disease in children. Rationale for corticosteroid immunomodulating therapy: pathogenic therapy]. Moggi C; Memmini G; Turini M; Ciulli L Pediatr Med Chir; 1996; 18(4):395-401. PubMed ID: 9064673 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines and cell response in surgery. Lin E; Calvano SE; Lowry SF Surgery; 2000 Feb; 127(2):117-26. PubMed ID: 10686974 [TBL] [Abstract][Full Text] [Related]
16. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Ben-Baruch A Semin Cancer Biol; 2006 Feb; 16(1):38-52. PubMed ID: 16139507 [TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and differentiated treatment of secondary immunodeficiencies]. Kolesnikov AP; Khabarov AS; Kozlov VA Ter Arkh; 2001; 73(4):55-9. PubMed ID: 11494450 [TBL] [Abstract][Full Text] [Related]
18. Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation. De Filippis D; D'Amico A; Iuvone T J Neuroendocrinol; 2008 May; 20 Suppl 1():20-5. PubMed ID: 18426495 [TBL] [Abstract][Full Text] [Related]